RPL39L Antibody
- 
								中文名稱:RPL39L兔多克隆抗體
- 
								貨號:CSB-PA850285LA01HU
- 
								規(guī)格:¥440
- 
								圖片:
- 
								其他:
產(chǎn)品詳情
- 
											產(chǎn)品名稱:Rabbit anti-Homo sapiens (Human) RPL39L Polyclonal antibody
- 
											Uniprot No.:
- 
											基因名:RPL39L
- 
											別名:RPL39L antibody; RPL39L1 antibody; 60S ribosomal protein L39-like antibody; 60S ribosomal protein L39-2 antibody; Large ribosomal subunit protein eL39-like antibody
- 
											宿主:Rabbit
- 
											反應種屬:Human
- 
											免疫原:Recombinant Human 60S ribosomal protein L39-like protein (1-51AA)
- 
											免疫原種屬:Homo sapiens (Human)
- 
											標記方式:Non-conjugated本頁面中的產(chǎn)品,RPL39L Antibody (CSB-PA850285LA01HU),的標記方式是Non-conjugated。對于RPL39L Antibody,我們還提供其他標記。見下表: 
- 
											克隆類型:Polyclonal
- 
											抗體亞型:IgG
- 
											純化方式:>95%, Protein G purified
- 
											濃度:It differs from different batches. Please contact us to confirm it.
- 
											保存緩沖液:Preservative: 0.03% Proclin 300
 Constituents: 50% Glycerol, 0.01M PBS, PH 7.4
- 
											產(chǎn)品提供形式:Liquid
- 
											應用范圍:ELISA, IHC
- 
											推薦稀釋比:Application Recommended Dilution IHC 1:20-1:200 
- 
											Protocols:
- 
											儲存條件:Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
- 
											貨期:Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
- 
											用途:For Research Use Only. Not for use in diagnostic or therapeutic procedures.
相關產(chǎn)品
Most popular with customers
- 
                                            
- 
                                            YWHAB Recombinant Monoclonal Antibody Applications: ELISA, WB, IHC, IF, FC Species Reactivity: Human, Mouse, Rat 
- 
                                            Phospho-YAP1 (S127) Recombinant Monoclonal Antibody Applications: ELISA, WB, IHC Species Reactivity: Human 
- 
                                            
- 
                                            
- 
                                            
- 
                                            
- 
                                            
 
  
 













 
         
           
  
          